HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
1.800
-0.080 (-4.26%)
At close: Jun 12, 2026, 4:00 PM EDT
1.890
+0.090 (5.00%)
After-hours: Jun 12, 2026, 7:58 PM EDT
HeartSciences Revenue
HeartSciences had revenue of $8.67K in the twelve months ending January 31, 2026. In the fiscal year ending April 30, 2025, HeartSciences had annual revenue of $4.35K, down -76.61%.
Revenue (ttm)
$8.67K
Revenue Growth
-76.61%
P/S Ratio
661.55
Revenue / Employee
$578
Employees
15
Market Cap
5.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 4.35K | -14.25K | -76.61% |
| Apr 30, 2024 | 18.60K | 13.45K | 261.17% |
| Apr 30, 2023 | 5.15K | -9.22K | -64.17% |
| Apr 30, 2022 | 14.37K | -11.23K | -43.86% |
| Apr 30, 2021 | 25.60K | -38.58K | -60.11% |
| Apr 30, 2020 | 64.18K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 19.57M |
| Beyond Air | 6.92M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 3.91M |
| IceCure Medical | 3.57M |
| ENvue Medical | 2.18M |
| Nexalin Technology | 275.58K |
HSCS News
- 3 days ago - HeartSciences granted European patent for heart-monitoring technology - TheFly
- 3 days ago - European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents - GlobeNewsWire
- 12 days ago - HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm - GlobeNewsWire
- 26 days ago - HeartSciences enters commercial agreement with North Shore Health - TheFly
- 26 days ago - HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network - GlobeNewsWire
- 5 weeks ago - HeartSciences signs MyoVista commercial agreement with St. Vincent Health - TheFly
- 5 weeks ago - HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - GlobeNewsWire
- 2 months ago - HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting - GlobeNewsWire